Hypha Labs, Inc. (FUNI) Fair Value 2026

FUNI · Diagnostics & Research ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.9 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (35/100)

Quick Summary — As of 2026-08-27, Hypha Labs, Inc. (FUNI) trades at $0.01. QOC: 3.9/10. Value Trap Risk: 35/100 (LOW). 0/13 models active.

Key Facts

Ticker
FUNI
Price
$0.01
Quality Score
3.9/10
Value Trap Risk
35/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 3.9/10 signals weak fundamentals

What Fair Value Does Each Model Give FUNI?

0 Intrinsic Value Models vs. Current Price ($0.01)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Hypha Labs, Inc. (FUNI) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Hypha Labs, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About FUNI?

0 of 13 models are currently active for FUNI. See which stocks rank higher →

How Does FUNI Rank in Diagnostics & Research?

Among 52 Diagnostics & Research stocks, FUNI ranks #48 by Quality of Company score. CirclFi's QOC score of 3.9/10 evaluates 32 fundamental signals. A score of 3.9 signals below-average fundamentals.

The Diagnostics & Research sector introduces analytical considerations specific to pharmaceutical industry businesses. For Hypha Labs, Inc., metrics like biosimilar competition timeline provide important context that general-purpose valuation models may underweight.

Is FUNI a Value Trap?

CirclFi's Value Trap algorithm assigns FUNI a score of 35/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Hypha Labs, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Hypha Labs, Inc. scores 3.9 out of 10 on our 32-signal quality assessment, a moderate rating that shows mixed signals across our quality framework with notable weaknesses. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every FUNI valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Hypha Labs, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Diagnostics & Research Stocks Should You Also Analyze?

11 related Diagnostics & Research stocks with 13-model coverage

NDRAENDRA Life Sciences Inc.QOC 4.0QGENQiagen N.V.QOC 3.2NSTMNovelStem International Corp.QOC 4.2ICLRICON Public Limited CompanyQOC 2.8PRPHProPhase Labs, Inc.QOC 4.8MBAIMBody AI Corp.QOC 2.5DHRDanaher CorporationQOC 8.1ADPTAdaptive Biotechnologies CorporationQOC 7.2BDSXBiodesix, Inc.QOC 6.3IDXXIDEXX Laboratories, Inc.QOC 9.5MEDPMedpace Holdings, Inc.QOC 9.3

Read investment analysis: NDRA · QGEN · NSTM · ICLR · PRPH · MBAI · DHR · ADPT · BDSX · IDXX · MEDP

Which Other Stocks Have a Similar Quality Score to FUNI?

7 companies across all industries closest to FUNI’s Quality of Company score of 3.9/10.

QGAIQuantum Genesis AI Corp.QOC 3.9EMPDEmpery Digital Inc.QOC 3.9OVTZOculus Inc.QOC 3.9KAYSKaya Holdings, Inc.QOC 3.9AIBTAibotics Inc.QOC 3.9ITOXIIOT-OXYS, Inc.QOC 3.8NVDANVIDIA CorporationQOC 10.0

Read investment analysis: QGAI · EMPD · OVTZ · KAYS · AIBT · ITOX · NVDA

What Else Do Investors Ask About Hypha Labs, Inc.’s Valuation?

What is Hypha Labs, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Hypha Labs, Inc. (FUNI). The Quality of Company score is 3.9/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is FUNI overvalued or undervalued right now?

At $0.01, 0 of 0 active models suggest FUNI may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Hypha Labs, Inc.'s business model in Diagnostics & Research.

What does a Quality of Company score of 3.9 mean for FUNI?

Hypha Labs, Inc.'s QOC of 3.9/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on FUNI?

CirclFi analyzes FUNI with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is FUNI a value trap in 2026?

Hypha Labs, Inc.'s Value Trap score is 35/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Hypha Labs, Inc. (FUNI) a Quality of Company score of 3.9/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/FUNI/ · Methodology
Primary sources for this FUNI valuation
  • Financial statements: Hypha Labs, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001502966) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for FUNI as of ; valuations recomputed .